Literature DB >> 6177790

Detection of circulating immune complexes by a C1q-microplate ELISA system.

V K Singh, A J Tingle.   

Abstract

A microscale ELISA system, designated as the 'C1q-micro ELISA,' has been developed for the measurement of circulating immune complexes. The sensitivity of the method ranged between 0.1 and 3 microgram equivalents of aggregated human gamma-globulins. The procedure requires small quantities of serum and reagents, and it can be performed with rapidity without the loss of accuracy and reproducibility.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6177790     DOI： 10.1016/0022-1759(82)90308-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


  8 in total

1.  Effects of cobra venom factor treatment on latent feline leukemia virus infection.

Authors:  E H Kraut; J L Rojko; R G Olsen; D L Tuomari
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

2.  Target organs of infection in guinea pigs with acquired congenital syphilis.

Authors:  K Wicher; F Abbruscato; V Wicher; R Baughn; G T Noordhoek
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  Rubella-associated arthritis. II. Relationship between circulating immune complex levels and joint manifestations.

Authors:  V K Singh; A J Tingle; M Schulzer
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

4.  Serologic and pathologic studies of mice immunized with homologous fibronectin.

Authors:  J E Murphy-Ullrich; T D Oberley; D F Mosher
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

5.  Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura.

Authors:  Y Kurata; S Hayashi; H Aochi; K Nagamine; M Oshida; H Mizutani; Y Tomiyama; T Tsubakio; T Yonezawa; S Tarui
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

6.  Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus.

Authors:  Min Chan Park; Yong Beom Park; Soo Kon Lee
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980

7.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

8.  In vitro and in vivo safety studies indicate that R15, a synthetic polyarginine peptide, could safely reverse the effects of unfractionated heparin.

Authors:  Tong Li; Zhiyun Meng; Xiaoxia Zhu; Hui Gan; Ruolan Gu; Zhuona Wu; Taoyun Liu; Peng Han; Jiarui Gao; Su Han; Guifang Dou
Journal:  FEBS Open Bio       Date:  2021-08-12       Impact factor: 2.693
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.